Autism spectrum disorders: From genes to neurobiology

Current Opinion in Neurobiology

Volumn 30, Issue , 2015, Pages 92-99

  Willsey, Jeremy ^a   State, Matthew W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METABOTROPIC RECEPTOR;

AUTISM; BRAIN REGION; EXON; FMR1 GENE; FRAGILE X SYNDROME; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; MISSENSE MUTATION; NLGN3X GENE; NLGN4X GENE; NONHUMAN; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PROTEIN SYNTHESIS; PTEN GENE; REVIEW; TSC1 GENE; TSC2 GENE; BRAIN; GENETIC PREDISPOSITION; GENETICS; GROWTH, DEVELOPMENT AND AGING; NEUROBIOLOGY; PATHOLOGY;

BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUROBIOLOGY;

EID: 84912101664     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2014.10.015     Document Type: Review

References (75)

1. Gaugler T., Klei L., Sanders S.J., Bodea C.A., Goldberg A.P., Lee A.B., Mahajan M., Manaa D., Pawitan Y., Reichert J., et al. Most genetic risk for autism resides with common variation. Nat Genet 2014, 46:881-885.
2. Klei L., Sanders S.J., Murtha M.T., Hus V., Lowe J.K., Willsey A.J., Moreno-De-Luca D., Yu T.W., Fombonne E., Geschwind D., et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism 2012, 3:9.
3. Weiss L.A., Arking D.E., Daly M.J., Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009, 461:802-808.
4. Wang K., Zhang H., Ma D., Bucan M., Glessner J.T., Abrahams B.S., Salyakina D., Imielinski M., Bradfield J.P., Sleiman P.M., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
5. Anney R., Klei L., Pinto D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., Sykes N., Pagnamenta A.T., et al. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet 2010, 19:4072-4082.
6. Devlin B., Melhem N., Roeder K. Do common variants play a role in risk for autism? Evidence and theoretical musings. Brain Res 2011, 1380:78-84.
7. Kremer E.J., Pritchard M., Lynch M., Yu S., Holman K., Baker E., Warren S.T., Schlessinger D., Sutherland G.R., Richards R.I. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 1991, 252:1711-1714.
8. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., Reiner O., Richards S., Victoria M.F., Zhang F.P., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65:905-914.
9. Pieretti M., Zhang F.P., Fu Y.H., Warren S.T., Oostra B.A., Caskey C.T., Nelson D.L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991, 66:817-822.
10. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
11. Li D.M., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997, 57:2124-2129.
12. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., et al. Identification of a candidate tumour suppressor gene MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15:356-362.
13. van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., Lindhout D., van den Ouweland A., Halley D., Young J., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997, 277:805-808.
14. Consortium E.C.T.S. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, 75:1305-1315.
15. Jamain S., Quach H., Betancur C., Råstam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003, 34:27-29.
16. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., Raynaud M., Ronce N., Lemonnier E., Calvas P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004, 74:552-557.
17. Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol 2009, 19:231-234.
18. Zoghbi H.Y. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 2003, 302:826-830.
19. Walsh C.A., Morrow E.M., Rubenstein J.L.R. Autism and brain development. Cell 2008, 135:396-400.
20. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
21. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008, 82:477-488.
22. Itsara A., Wu H., Smith J.D., Nickerson D.A., Romieu I., London S.J., Eichler E.E. De novo rates and selection of large copy number variation. Genome Res 2010, 20:1469-1481.
23. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
24. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
25. Levy D., Ronemus M., Yamrom B., Lee Y.H., Leotta A., Kendall J., Marks S., Lakshmi B., Pai D., Ye K., et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011, 70:886-897.
26. Pinto D., Delaby E., Merico D., Barbosa M., Merikangas A., Klei L., Thiruvahindrapuram B., Xu X., Ziman R., Wang Z., et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet 2014, 94:677-694.
27. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008, 358:667-675.
28. Kumar R.A., KaraMohamed S., Sudi J., Conrad D.F., Brune C., Badner J.A., Gilliam T.C., Nowak N.J., Cook E.H., Dobyns W.B., et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008, 17:628-638.
29. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., Liu X.Q., Vincent J.B., Skaug J.L., Thompson A.P., Senman L., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007, 39:319-328.
30. Moreno-De-Luca D., Sanders S.J., Willsey A.J., Mulle J.G., Lowe J.K., Geschwind D.H., State M.W., Martin C.L., Ledbetter D.H. Using large clinical data sets to infer pathogenicity for rare copy number variants in autism cohorts. Mol Psychiatry 2013, 18:1090-1095.
31. O'Roak B.J., Deriziotis P., Lee C., Vives L., Schwartz J.J., Girirajan S., Karakoc E., Mackenzie A.P., Ng S.B., Baker C., et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011, 43:585-589.
32. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
33. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
34. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., Lin C.F., Stevens C., Wang L.S., Makarov V., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245.
35. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y-h, Narzisi G., Leotta A., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74:285-299.
36. Dong S., Walker M., Carrerio N., DiCola M., Willsey A., Ye A., Waqar Z., Gonzalez L., Overton J., Frahm S., et al. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep 2014, 9:16-23. 10.1016/j.celrep.2014.08.068.
37. Willsey A.J., Sanders Stephan J., Li M., Dong S., Tebbenkamp Andrew T., Muhle Rebecca A., Reilly Steven K., Lin L., Fertuzinhos S., Miller Jeremy A., et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 2013, 155:997-1007.
38. Iossifov I., O'Roak B.J., Sanders S.J., Ronemus M., Krumm N., Levy D., Stessman H.A., Witherspoon K.T., Vives L., Patterson K.E., et al. The contribution of de novo coding mutations to autismspectrum disorder. Nature 2014, 515:216-221. PubMed PMID: 25363768. 10.1038/nature13908.
39. De Rubeis S., He X., Goldberg A.P., Poultney C.S., Samocha K., Ercument Cicek A., Kou Y., Liu L., Fromer M., Walker S., et al. Synaptic, transcriptional and chromatin genes disrupted inautism. Nature 2014, 515:209-215. PubMed PMID: 25363760. 10.1038/nature13772.
40. Buxbaum J.D., Daly M.J., Devlin B., Lehner T., Roeder K., State M.W., Consortium T.A.S. The autism sequencing consortium: large-scale high-throughput sequencing in autism spectrum disorders. Neuron 2012, 76:1052-1056.
41. Kong A., Frigge M.L., Masson G., Besenbacher S., Sulem P., Magnusson G., Gudjonsson S.A., Sigurdsson A., Jonasdottir A., Wong W.S., et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012, 488:471-475.
42. O'Roak B.J., Vives L., Fu W., Egertson J.D., Stanaway I.B., Phelps I.G., Carvill G., Kumar A., Lee C., Ankenman K., et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012, 338:1619-1622.
43. He X., Sanders S.J., Liu L., De Rubeis S., Lim E.T., Sutcliffe J.S., Schellenberg G.D., Gibbs R.A., Daly M.J., Buxbaum J.D., et al. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLOS Genet 2013, 9:e1003671.
44. Liu L., Lei J., Sanders S.J., Willsey A.J., Kou Y., Cicek A.E., Klei L., Lu C., He X., Li M., et al. DAWN: a framework to identify autism genes and subnetworksusing gene expression and genetics. Mol Autism 2014, 5:22. PubMed PMID: 24602502; PubMed Central PMCID: PMC4016412. 10.1186/2040-2392-5-22.
45. Moy S.S., Nadler J.J. Advances in behavioral genetics: mouse models of autism. Mol Psychiatry 2008, 13:4-26.
46. Ehninger D., Li W., Fox K., Stryker M.P., Silva A.J. Reversing neurodevelopmental disorders in adults. Neuron 2008, 60:950-960.
47. Krueger D.D., Bear M.F. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 2011, 62:411-429.
48. Castren E., Elgersma Y., Maffei L., Hagerman R. Treatment of neurodevelopmental disorders in adulthood. J Neurosci 2012, 32:14074-14079.
49. Bhakar A.L., Dolen G., Bear M.F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci 2012, 35:417-443.
50. van der Voet M., Nijhof B., Oortveld M.A., Schenck A. Drosophila models of early onset cognitive disorders and their clinical applications. Neurosci Biobehav Rev 2014, pii: S0149-7634(14)00057-8; [Epub ahead of print]. 10.1016/j.neubiorev.2014.01.013.
51. Ashley C.T., Wilkinson K.D., Reines D., Warren S.T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 1993, 262:563-566.
52. Kielinen M., Rantala H., Timonen E., Linna S.L., Moilanen I. Associated medical disorders and disabilities in children with autistic disorder: a population-based study. Autism 2004, 8:49-60.
53. Reddy K.S. Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder. BMC Med Genet 2005, 6:3.
54. Hatton D.D., Sideris J., Skinner M., Mankowski J., Bailey D.B., Roberts J., Mirrett P. Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP. Am J Med Genet A 2006, 140a:1804-1813.
55. Clifford S., Dissanayake C., Bui Q.M., Huggins R., Taylor A.K., Loesch D.Z. Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord 2007, 37:738-747.
56. Gillberg I.C., Gillberg C., Ahlsen G. Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study. Dev Med Child Neurol 1994, 36:50-56.
57. Fombonne E., Du Mazaubrun C., Cans C., Grandjean H. Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry 1997, 36:1561-1569.
58. Lewis J.C., Thomas H.V., Murphy K.C., Sampson J.R. Genotype and psychological phenotype in tuberous sclerosis. J Med Genet 2004, 41:203-207.
59. Wong V. Study of the relationship between tuberous sclerosis complex and autistic disorder. J Child Neurol 2006, 21:199-204.
60. Muzykewicz D.A., Newberry P., Danforth N., Halpern E.F., Thiele E.A. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav 2007, 11:506-513.
61. Goffin A., Hoefsloot L.H., Bosgoed E., Swillen A., Fryns J.P. PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 2001, 105:521-524.
62. Butler M.G., Dasouki M.J., Zhou X.P., Talebizadeh Z., Brown M., Takahashi T.N., Miles J.H., Wang C.H., Stratton R., Pilarski R., et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 2005, 42:318-321.
63. Varga E.A., Pastore M., Prior T., Herman G.E., McBride K.L. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 2009, 11:111-117.
64. McBride K.L., Varga E.A., Pastore M.T., Prior T.W., Manickam K., Atkin J.F., Herman G.E. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res 2010, 3:137-141.
65. Garg S., Lehtonen A., Huson S.M., Emsley R., Trump D., Evans D.G., Green J. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol 2013, 55:139-145.
66. State M.W., Šestan N. The emerging biology of autism spectrum disorders. Science 2012, 337:1301-1303.
67. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
68. Ben-David E., Shifman S. Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol Psychiatry 2013, 18:1054-1056.
69. Kang H.J., Kawasawa Y.I., Cheng F., Zhu Y., Xu X., Li M., Sousa A.M.M., Pletikos M., Meyer K.A., Sedmak G., et al. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489.
70. Miller J.A., Ding S.L., Sunkin S.M., Smith K.A., Ng L., Szafer A., Ebbert A., Riley Z.L., Royall J.J., Aiona K., et al. Transcriptional landscape of the prenatal human brain. Nature 2014, 508:199-206.
71. Parikshak Neelroop N., Luo R., Zhang A., Won H., Lowe Jennifer K., Chandran V., Horvath S., Geschwind Daniel H. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021.
72. Xu X., Wells A.B., O'Brien D.R., Nehorai A., Dougherty J.D. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci 2014, 34:1420-1431.
73. Uddin M., Tammimies K., Pellecchia G., Alipanahi B., Hu P., Wang Z., Pinto D., Lau L., Nalpathamkalam T., Marshall C.R., et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat Genet 2014, 46:742-747.
74. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13.
75. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.